Loading...
End-UseCategory 4
U.S. imports of pharmaceutical preparations (End-Use 40100) totaled $15.0B in April 2026, traded with 94 countries.
Importers of Pharmaceutical Preparations paid $21.0M in duties in April 2026 — an effective duty rate of 9.0% on $234.1M in dutiable value, based on actual customs collections rather than the published tariff schedule. Pharmaceutical Preparations imports of $15.0B in April 2026 ran 11% above the year-to-date monthly average of $13.6B.
Last updated: April 2026 dataFDA admissibility review governs all imported pharmaceutical preparations, which must originate from facilities registered with FDA and comply with current Good Manufacturing Practice requirements before entry into US commerce. Import classification distinguishes among finished dosage forms packaged for retail sale, bulk active pharmaceutical ingredients, and veterinary medicaments — distinctions that carry real duty and regulatory consequences. Supply-chain resilience has become a heightened concern in this category, as concentration of API manufacturing in a small number of foreign countries has drawn sustained attention from both regulators and procurement professionals.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
FDA may issue a Notice of Action detaining a pharmaceutical shipment if the product appears to be adulterated, misbranded, or from an unregistered facility. The importer of record typically has an opportunity to submit testimony or reconditioning proposals to bring the goods into compliance. If the detention is not resolved, FDA can refuse admission and require the goods to be re-exported or destroyed. Working with a licensed customs broker and an FDA regulatory consultant before shipment is the most effective way to avoid detention.
Bulk APIs are generally classified under HTS Chapter 29 (organic chemicals) or Chapter 28 (inorganic chemicals) based on their chemical structure, while finished dosage forms — tablets, capsules, solutions, and similar preparations — are classified under Chapter 30 as medicaments. This distinction affects not only the duty rate but also the FDA import alert and admissibility framework that applies, since finished dosage forms trigger different review procedures than bulk chemical imports.
End-Use codes describe different products on the import and export sides. Cross-direction exports are not shown for this slug.
Monthly import values over time
Supplier Network
Get discovered by U.S. importers searching for HS 40100 — Pharmaceutical Preparations. Be the first supplier listed.